Lactate Dehydrogenase to Albumin ratio as a Predictive Factor of COVID-19 Patients' Outcome; a Cross-sectional Study

被引:12
|
作者
Alizadeh, Nafiseh [1 ]
Tabatabaei, Fatemeh-sadat [2 ]
Azimi, Amirali [3 ]
Faraji, Neda [4 ]
Akbarpour, Samaneh [5 ]
Dianatkhah, Mehrnoush [6 ]
Moghaddas, Azadeh [7 ]
机构
[1] Univ Tehran Med Sci, Baharlou Hosp, Dept Pharmaceut Care, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Mens Hlth & Reprod Hlth Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Baharlou Hosp, Dept Internal Med, Tehran, Iran
[5] Univ Tehran Med Sci, Baharlou Hosp, Occupat Sleep Res Ctr, Tehran, Iran
[6] Isfahan Univ Med Sci, Dept Clin Pharm, Esfahan, Iran
[7] Isfahan Univ Med Sci, Dept Clin Pharm & Pharm Practice, Sch Pharm & Pharmaceut Sci, Canc Prevent Res Ctr,Seyyed Al Shohada Hosp, Esfahan, Iran
关键词
SerumAlbumin; L-Lactate Dehydrogenase; COVID-19; Prognosis; Emergency Service; Hospital; SEPSIS;
D O I
10.22037/aaem.v10i1.1646
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Despite the increasing vaccination coverage, COVID-19 is still a concern. With the limited health care capacity, early risk stratification is crucial to identify patients who should be prioritized for optimal management. The present study investigates whether on-admission lactate dehydrogenase to albumin ratio (LAR) can be used to predict COVID-19 outcomes. Methods: This retrospective cross-sectional study evaluated hospitalized COVID-19 patients in an academic referral center in Iran from May 2020 to October 2020. The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the value of LAR in the prediction ofmortality. The Yuden index was used to find the optimal cut-off of LAR to distinguish severity. Patients were classified into three groups (LAR tertiles), first: LAR<101.46, second: 101.46 <= LAR< 148.78, and third group: LAR >= 148.78. Logistic regression analysis was used to identify the association between tertiles of LAR, as well as the relationship between each one-unit increase in LAR with mortality and ICU admission in three models, based on potential confounding variables. Results: A total of 477 patients were included. Among all patients, 100 patients (21%) died, and 121 patients (25.4%) were admitted to intensive care unit (ICU). In the third group, the risk of mortality and ICU admission increased 7.78 times (OR=7.78, CI: 3.95-15.26; p <0.0001) and 4.49 times (OR=4.49, CI: 2.01-9.04; p <0.0001), respectively, compared to the first group. The AUC of LAR for prediction of mortality was 0.768 (95% CI 0.69- 0.81). LAR >= 136, with the sensitivity and specificity of 72% (95%CI: 62.1-80.5) and 70% (95%CI: 64.9-74.4), respectively, was the optimal cut-off value for predicting mortality. Conclusion: High LAR was associated with higher odds of COVID-19 mortality, ICU admission, and length of hospitalization. On-admission LAR levels might help health care workers identify critical patients early on.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Complications of prone positioning in patients with COVID-19: A cross-sectional study
    Binda, Filippo
    Galazzi, Alessandro
    Marelli, Federica
    Gambazza, Simone
    Villa, Lucia
    Vinci, Elisa
    Adamini, Ileana
    Laquintana, Dario
    INTENSIVE AND CRITICAL CARE NURSING, 2021, 67
  • [22] Neurological manifestations in hospitalized COVID-19 patients: a cross-sectional study
    Davood Kashipazha
    Davood Shalilahmadi
    Gholamreza Shamsaei
    Nastaran Farahmand Porkar
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 60
  • [23] Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study
    Fernandes, Tatiana Jorge
    Ogrzewalska, Maria
    Martins, Ezequias Batista
    de Siqueira, Marilda Agudo Mendonca Teixeira
    Brasil, Patricia
    Calvet, Guilherme Amaral
    BMC ORAL HEALTH, 2023, 23 (01)
  • [24] Chemosensory function recovery in COVID-19 patients: A cross-sectional study
    Nawab, Aria
    Acosta, Aura
    Levine, Corinna G.
    Hoffer, Michael E.
    Casiano, Roy
    Liu, Xue Zhong
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (01)
  • [25] Mortality and Associated Factors in Patients with COVID-19: Cross-Sectional Study
    Carvalho, Vergilio Pereira
    Pontes, Joao Paulo Jordao
    Neto, Democrito Ribeiro de Brito
    Borges, Celso Eduardo Rezende
    Campos, Gisele Ribeiro Londe
    Ribeiro, Hugo Leonardo Shigenaga
    do Amaral, Waldemar Naves
    VACCINES, 2023, 11 (01)
  • [26] Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study
    Tatiana Jorge Fernandes
    Maria Ogrzewalska
    Ezequias Batista Martins
    Marilda Agudo Mendonça Teixeira de Siqueira
    Patrícia Brasil
    Guilherme Amaral Calvet
    BMC Oral Health, 23
  • [27] Echocardiographic and electrocardiographic findings in COVID-19 patients: a cross-sectional study
    Faeze Keihanian
    Hoorak Poorzand
    Amin Saeidinia
    Ali Eshraghi
    The International Journal of Cardiovascular Imaging, 2022, 38 : 2167 - 2175
  • [28] ABO blood groups in COVID-19 patients; Cross-sectional study
    Solmaz, Ihsan
    Arac, Songul
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [29] Echocardiographic features of patients with COVID-19 infection: a cross-sectional study
    Hasan Ali Barman
    Adem Atici
    Esra Aktas Tekin
    Omer Faruk Baycan
    Gokhan Alici
    Bengisu Keskin Meric
    Omer Sit
    Omer Genc
    Fahri Er
    Baris Gungor
    Irfan Sahin
    Namigar Turgut
    The International Journal of Cardiovascular Imaging, 2021, 37 : 825 - 834
  • [30] The lactate dehydrogenase to lymphocyte ratio in evaluating the prognosis of patients with severe COVID-19
    Bennai, Redouane Mammar
    Boudbellah, Mounya
    Benabdelouahab, Nada
    El Amri, Badr-Eddine
    Benchekroun, Laila
    ANNALES DE BIOLOGIE CLINIQUE, 2023, 81 (05) : 491 - 497